With the Gem/Cis/Durvalumab regimen now FDA approved in MIBC - are you dose reducing/omitting IV Dexamethasone as a pre-medication for anti-emesis?   

Not routinely, however, assessment of comorbid conditions such as uncontrolled diabetes remains standard. In the recent approval with continuation in the adjuvant space, it may be considered.